Venture Capital / Buyout
We help the people of today, build the companies of tomorrow.
Venture Capital / Buyout
We help the people of today, build the companies of tomorrow.
Venture Capital / Buyout
We help the people of today, build the companies of tomorrow.
Venture Capital / Buyout
We help the people of today, build the companies of tomorrow.

Our Approach

Wille Finance provides capital, operational experience and a network to both growth companies and established businesses looking for a strong financial partner. Our mission is to help organisations become successful and enduring businesses.

Wille Finance is defined by respect and trust for the entrepreneur and the company; we know what it’s like to be in the entrepreneur’s shoes. The team is composed of former founders / managers who have domain expertise ranging from industrial management through ICT to Life-Science and banking industry.

Our Focus

Venture Capital & Buyout

Stage

Venture Capital
Series A & B
Buyout
Small & Mid Cap (EBITDA CHF 2 - 10 Mio)

Geography

Venture Capital
Europe
Buyout
DACH / Europe (Opportunistic)

Industry

Venture Capital
ICT (B2B) / Biotech & Medtech
Buyout
Buy & Build / Asset Light (Sector Agnostic)

Ticket

Venture Capital
CHF 1 - 6 Mio (Initial Ticket)
Buyout
CHF 5 - 20 Mio (Initial Ticket)

WHO WE ARE

OUR PHILOSOPHY

Long-Term

As a family office, Wille Finance has a long term investment approach, with no pressure to exit. We have the financial capacity to be an anchor investor over several investment rounds.

Loyal Partner

We see an investment as a partnership both ways – we are committed to support a portfolio company with capital, our experience and network.

Entrepreneurial Spirit

Our passion is to help entrepreneurs to build great companies. We are fast, lean and clear in our decisions.

Our Portfolio

An overview of our current and past investments
Visual Portfolio, Posts & Image Gallery for WordPress
All
ICT
Life Sciences
Araris Logo

Araris

Araris is pioneering the development of a novel antibody-drug conjugate (ADC)-linker technology that enables payload attachment to ‘off-the-shelf’ antibodies in one step.
Ava Logo

Ava

Ava provides women a fertility and pregnancy tracking solution based on live data collected by a wearable.
Eyenovia Logo

Eyenovia

Eyenovia is a clinical stage company transforming the delivery of therapeutics for the treatment of prominent eye diseases.
Hillo Logo

Hillo

Hillo supports diabetic patients in treatment decision making with an AI tool for personal glycemia level prediction.
ImmunOs Therapeutics Logo

ImmunOs

ImmunOs is leading in the discovery and development of the next generation of novel human immunomodulatory proteins for cancer treatment.
Kamari Pharma Logo

Kamari Pharma

Kamari Pharma is a clinical-stage biopharmaceutical company developing small molecule inhibitors of TRPV3 for the treatment of dermatological conditions with unmet need.
NETRIS Pharma Logo

NETRIS Pharma

NETRIS Pharma is a clinical stage immuneoncology company targeting the biology of dependence receptors.
Newronika Logo

Newronika

Newronika builds innovative brain devices adapting patient's therapy following real time changes in deep neuronal networks.
Oculis Logo

Oculis

Oculis is a clinical-stage biopharmaceutical company developing novel topical treatments for ophthalmic diseases for back & front of the eye.
Peripal Logo

Peripal

Peripal is a novel device for peritoneal dialysis patients, supporting all patients who wish to opt for home dialysis.
Polyneuron Logo

Polyneuron

Polyneuron engages in the development of a new drug class for the treatment of antibody-mediated autoimmune disorders.
Raziel Therapeutics Logo

Raziel Therapeutics

Raziel Therapeutics is developing a proprietary new drug for aesthetic applications, and fat disorders with a single injection treatment into subcutaneous fat.
Redbiotec Logo

Redbiotec

Redbiotec develops immunotherapies against Herpes and Cancer based on best-in-class proteins and microorganisms.
Spiral Therapeutics Logo

Spiral Therapeutics

Spiral is a clinical stage company focused on the development of first-in-class therapies to target hearing loss and other inner ear disorders.
T3 Pharma Logo

T3 Pharma

T3 is a pre-clinical company working to advance new generation therapies for cancer patients using live bacteria.
Tolremo Logo

Tolremo

Tolremo engages in the discovery and development of molecule drugs targeting drug resistance in cancer therapy.
Visus Logo

Visus

Visus is a clinical-stage pharmaceutical company developing presbyopia-correcting eye-drop.
View More Loading... You’ve reached the end of the list
Visual Portfolio, Posts & Image Gallery for WordPress
All
ICT
Life Sciences
Araris Logo
Araris is pioneering the development of a novel antibody-drug conjugate (ADC)-linker technology that enables payload attachment to ‘off-the-shelf’ antibodies in...
Ava Logo
Ava provides women a fertility and pregnancy tracking solution based on live data collected by a wearable.
Eyenovia Logo
Eyenovia is a clinical stage company transforming the delivery of therapeutics for the treatment of prominent eye diseases.
Hillo Logo
Hillo supports diabetic patients in treatment decision making with an AI tool for personal glycemia level prediction.
ImmunOs Therapeutics Logo
ImmunOs is leading in the discovery and development of the next generation of novel human immunomodulatory proteins for cancer treatment.
Kamari Pharma Logo
Kamari Pharma is a clinical-stage biopharmaceutical company developing small molecule inhibitors of TRPV3 for the treatment of dermatological conditions with...
NETRIS Pharma Logo
NETRIS Pharma is a clinical stage immuneoncology company targeting the biology of dependence receptors.
Newronika Logo
Newronika builds innovative brain devices adapting patient's therapy following real time changes in deep neuronal networks.
Oculis Logo
Oculis is a clinical-stage biopharmaceutical company developing novel topical treatments for ophthalmic diseases for back & front of the eye.
Peripal Logo
Peripal is a novel device for peritoneal dialysis patients, supporting all patients who wish to opt for home dialysis.
Polyneuron Logo
Polyneuron engages in the development of a new drug class for the treatment of antibody-mediated autoimmune disorders.
Raziel Therapeutics Logo
Raziel Therapeutics is developing a proprietary new drug for aesthetic applications, and fat disorders with a single injection treatment into...
View More Loading... You’ve reached the end of the list

Private Equity Numbers

Investment Professionals
0
Opportunities / Year
> 0
Portfolio Companies
0
Exits
0

Partner With Wille Finance

At Wille Finance we are always looking for interesting companies to support. Follow the link below and tell us more about your vision.

Partner Now
Wille Finance White Logo

Wille Finance AG

Wille Finance Blue Logo

Wille Finance AG

Scroll to Top